Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 2, 2016, Pages 219-227

  Lacourse, Sylvia M ^a   Cranmer, Lisa M ^b,c   Matemo, Daniel ^d   Kinuthia, John ^d,e   Richardson, Barbra A ^f   John Stewart, Grace ^a,b,g,h   Horne, David J ^a,h  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Departments of Reproductive Health   (United States)

^e KENYATTA NATIONAL HOSPITAL   (Kenya)

^f Departments of Biostatistics   (United States)

^g Department of Epidemiology ^*  (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HIV; pregnancy; screening; tuberculosis; urine TB LAM; Xpert

Indexed keywords

ANTIRETROVIRUS AGENT; LIPOARABINOMANNAN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COUGHING; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; LIQUID CULTURE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; SYMPTOM; TUBERCULIN TEST; TUBERCULOSIS CONTROL; COMPLICATION; MASS SCREENING; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV INFECTIONS; HUMANS; KENYA; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; SPUTUM; SURVEYS AND QUESTIONNAIRES; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84955739610     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000826     Document Type: Article

References (49)

1. Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis. 2012;55: 1532-1549.
2. Walson JL, Brown ER, Otieno PA, et al. Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up. J Acquir Immune Defic Syndr. 2007;46:208-215.
3. Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis. 2007;45:241-249.
4. Toro PL, Schneider KL, Carter RJ, et al. Maternal and infant outcomes with concurrent treatment of tuberculosis and HIV infection in pregnant women. J Acquir Immune Defic Syndr. 2011;56:e63-e66.
5. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS. 2003;17:1398-1400.
6. Getahun H, Sculier D, Sismanidis C, et al. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis. 2012;205 (suppl 2):S216-S227.
7. Gounder C, Wada N, Kensler C, et al. Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa. J Acquir Immune Defic Syndr. 2011;57:e77-e84.
8. Deluca A, Chaisson RE, Martinson NA. Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health. J Acquir Immune Defic Syndr. 2009;50:196-199.
9. World Health Organization. Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings. 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241500708-eng.pdf. Accessed December 1, 2014.
10. Hoffmann CJ, Variava E, Rakgokong M, et al. High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa. PLoS One. 2013;8: e62211.
11. Kancheya N, Luhanga D, Harris J, et al. Integrating active tuberculosis case finding in antenatal services in Zambia. Int J Tuberc Lung Dis. 2014;18:1466-1472.
12. Getahun H, Kittikraisak W, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.
13. Ratnapalan S, Bona N, Chandra K, et al. Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. Am J Roentgenol. 2004;182:1107-1109.
14. Kenya National AIDS and STI Control Programme (NASCOP). Guidelines for Prevention of Mother to Child Transmission (PMTCT) of HIV/AIDS in Kenya. 4th ed. 2012. Available at: http://www.faces-kenya. org/wp-content/uploads/2012/11/Guidelines-for-PMTCT-of-HIVAIDS-in-Kenya-1-2012.pdf. Accessed December 15, 2014.
15. Kenya National AIDS and STI Control Programme (NASCOP). Kenya AIDS Indicator Survey 2012: Final Report. 2014. Available at: http://www.nacc.or. ke/images/documents/KAIS-2012.pdf. Accessed December 15, 2014.
16. Kenya National AIDS and STI Control Programme (NASCOP). Guidelines for HIV Testing and Counselling in Kenya. 2010. Available at: http://nascop.or.ke/hiv-testing-&-counselling.php. Accessed December 15, 2014.
17. Cobelens F, Van Deutekom H, Draayer-Jansen I, et al. Tuberculin skin test reactions by time of reading among Dutch travellers. Int J Tuberc Lung Dis. 2003;7:758-763.
18. Tuberculin reaction size on five consecutive days. Bull World Health Organ. 1955;12:189-196.
19. Targeted tuberculin testing and treatment of latent tuberculosis infection. Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med. 2000;161:S221-S247.
20. Alere. Alere Determine TB LAM Ag [Pakage Insert]. 2013. Available at: http://www.alere.com/ww/en/product-details/determine-tb-lam. html. Accessed November 20, 2014.
21. Kenyan Ministry of Health, National AIDS and STI Control Program (NASCOP). Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: A Rapid Advice. 2014. Available at: http://healthservices.uonbi.ac.ke/sites/default/files/centraladmin/healthservices/Rapid%20Advice%20Booklet%202014%2024%20June%2012%20noon-0. pdf. Accessed December 15, 2014.
22. van't Hoog AH, Laserson KF, Githui WA, et al. High prevalence of pulmonary tuberculosis and inadequate case finding in rural western Kenya. Am J Respir Crit Care Med. 2011;183:1245-1253.
23. Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J. 2001;91:983-987.
24. Kali PB, Gray GE, Violari A, et al. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006;42: 379-381.
25. Modi S, Cavanaugh S, Shiraishi R, et al. Symptom-based screening for tuberculosis among pregnant women living with HIV in Kenya. Paper presented at: Conference of Retroviruses and Opportunistic Infections (CROI); March 3-6, 2014; Boston, MA.
26. Gupta A, Chandrasekhar A, Gupte N, et al. Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis. Clin Infect Dis. 2011;53: 1015-1018.
27. Lawn SD, Wood R, De Cock KM, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10: 489-498.
28. Gupta A, Wood R, Kaplan R, et al. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One. 2012;7:e34156.
29. Kufa T, Mabuto T, Muchiri E, et al. Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis. PLoS One. 2014;9: e111209.
30. Lawn SD, Myer L, Edwards D, et al. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23:1717-1725.
31. Rangaka MX, Wilkinson RJ, Glynn JR, et al. Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. Clin Infect Dis. 2012;55:1698-1706.
32. Ahmad Khan F, Verkuijl S, Parrish A, et al. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped. AIDS. 2014;28:1463-1472.
33. Long NH, Diwan VK, Winkvist A. Difference in symptoms suggesting pulmonary tuberculosis among men and women. J Clin Epidemiol. 2002; 55:115-120.
34. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest. 1992; 101:1114-1120.
35. Singh N, Perfect JR. Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis. 2007;45:1192-1199.
36. Ververs MT, Antierens A, Sackl A, et al. Which anthropometric indicators identify a pregnant woman as acutely malnourished and predict adverse birth outcomes in the humanitarian context? PLoS Curr. 2013;5.
37. Sheriff F, Manji K, Manji M, et al. Pulmonary tuberculosis among pregnant mothers in Tanzania. Dar Es Salaam Med Stud J. 2010;16:5-9.
38. Turnbull ER, Kancheya NG, Harris JB, et al. A model of tuberculosis screening for pregnant women in resource-limited settings ssing Xpert MTB/RIF. J Pregnancy. 2012;2012:565049.
39. Steingart KR, Schiller I, Horne DJ, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1:CD009593.
40. Balcells ME, Garcia P, Chanqueo L, et al. Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile. Int J Tuberc Lung Dis. 2012;16:1349-1353.
41. Carriquiry G, Otero L, Gonzalez-Lagos E, et al. A diagnostic accuracy study of Xpert(R)MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. PLoS One. 2012;7: e44626.
42. Lawn SD, Brooks SV, Kranzer K, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011;8: e1001067.
43. Shah M, Ssengooba W, Armstrong D, et al. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS. 2014;28:1307-1314.
44. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis. 2012;12:103.
45. Kaforou M, Wright VJ, Oni T, et al. Detection of tuberculosis in HIV-infected and-uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med. 2013;10:e1001538.
46. Anderson ST, Kaforou M, Brent AJ, et al. Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med. 2014; 370:1712-1723.
47. Naranbhai V, Moodley D, Chipato T, et al. The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women. J Acquir Immune Defic Syndr. 2014;67: 573-575.
48. Drain PK, Mayeza L, Bartman P, et al. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa. Int J Tuberc Lung Dis. 2014;18:20-26.
49. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926-930.